Sarclisa (siltuximab) in combination with bortezomib, lenalidomide, and dexamethasone (VRd) as a first-line treatment option ...
The FDA has approved Sarclisa (isatuximab) as a first-line therapy for blood cancer multiple myeloma as a combination regimen ...
Hosted on MSN20h
Moving mountains: Boulder woman's battle against multiple myeloma during Blood Cancer Awareness MonthA Boulder woman is opening up about her fight with multiple myeloma during Blood Cancer Awareness Month. She went from being ...
In addition to other MM indications, Isatuximab's anti-CD38 competitor on the US market, daratumumab (Darzalex — Johnson & Johnson), also carries a first-line indication for transplant-ineligible MM ...
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical ...
XPOVIO® is the first and only approved XPO1 inhibitor in Thailand. XPOVIO® has been approved for multiple indications in nine markets across the APAC region. Antengene has submitted a new drug applica ...
Springsteen and the E Street Band returned to their old stomping grounds and delivered a concert for the ages Bruce ...
HMP Global is set to host its first Lymphoma, Leukemia & Myeloma (LL&M) Winter Symposium, a pivotal event for healthcare ...
The set also marked the return of backup singer Patti Scialfa during “Tougher Than the Rest” after she’d sat out a number of ...
Patients will have access to TGH and MGB providers for radiation oncology, medical imaging, and clinical oncology.
In one study, men with priapism related to sickle cell disease found that exercise alone or in combination with warm or cold ...
The stories of fallen IDF soldiers Yosef Malachi Guedalia, Dekel Suisa, and Aviad and Erez Deri – and those who mourned them at Mount Herzl military cemetery, months and years later. The police ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback